In vivo biodistribution and small animal PET of 64Cu-labeled antimicrobial peptoids

Bioconjugate Chemistry

Volumn 23, Issue 5, 2012, Pages 1069-1079

  Seo, Jiwon ^b   Ren, Gang ^a   Liu, Hongguang ^a   Miao, Zheng ^a   Park, Minyoung ^a   Wang, Yihong ^a   Miller, Tyler M ^c   Barron, Annelise E ^c   Cheng, Zhen ^a  

^a STANFORD UNIVERSITY   (United States)

^b Gwangju Institute of Science and Technology (GIST)   (South Korea)

^c Stanford University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ANIMALS; BACTERIA; BIOCHEMISTRY; BIOMIMETICS; CELL MEMBRANES; PHARMACOKINETICS; POSITRON EMISSION TOMOGRAPHY;

BIODISTRIBUTIONS; BIOMIMETIC POLYMERS; IN-VIVO; NATURAL-ANTIMICROBIALS; PEPTOIDS; POLYMER BASED; PROPERTY; SMALL ANIMAL POSITRON EMISSION TOMOGRAPHIES; VIVO BIODISTRIBUTION; VIVO PHARMACOKINETICS;

PEPTIDES;

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID PEPTOID CONJUGATE CU 64; COPPER 64; GLYCINE; PEPTIDOMIMETIC AGENT; PEPTOID; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL MEMBRANE PERMEABILITY; CONJUGATE; DIGESTION; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG POTENCY; DRUG STABILITY; DRUG UPTAKE; GASTROINTESTINAL TRACT; HYDROPHOBICITY; IN VIVO STUDY; ISOTOPE LABELING; KIDNEY; LIVER; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; PEPTIDE SYNTHESIS; POSITRON EMISSION TOMOGRAPHY; RELIABILITY;

ANIMALIA;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; COPPER RADIOISOTOPES; HETEROCYCLIC COMPOUNDS, 1-RING; MICE; MICE, INBRED BALB C; PEPTIDES; PEPTIDOMIMETICS; POSITRON-EMISSION TOMOGRAPHY; TISSUE DISTRIBUTION;

EID: 84861111856     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300091d     Document Type: Article

References (66)

1. Hancock, R. E. W. and Sahl, H. G. (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies Nat. Biotechnol. 24, 1551-1557
2. Mygind, P. H., Fischer, R. L., Schnorr, K. M., Hansen, M. T., Sonksen, C. P., Ludvigsen, S., Raventos, D., Buskov, S., Christensen, B., De Maria, L., Taboureau, O., Yaver, D., Elvig-Jorgensen, S. G., Sorensen, M. V., Christensen, B. E., Kjaerulff, S., Frimodt-Moller, N., Lehrer, R. I., Zasloff, M., and Kristensen, H. H. (2005) Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus Nature 437, 975-980
3. Brown, K. L. and Hancock, R. E. W. (2006) Cationic host defense (antimicrobial) peptides Curr. Opin. Immunol. 18, 24-30
4. Zasloff, M. (1992) Antibiotic peptides as mediators of innate immunity Curr. Opin. Immunol. 4, 3-7
5. Hamill, P., Brown, K., Jenssen, H., and Hancock, R. E. (2008) Novel anti-infectives: is host defence the answer? Curr. Opin. Biotechnol. 19, 628-636
6. Scott, M. G., Dullaghan, E., Mookherjee, N., Glavas, N., Waldbrook, M., Thompson, A., Wang, A., Lee, K., Doria, S., Hamill, P., Yu, J. J., Li, Y., Donini, O., Guarna, M. M., Finlay, B. B., North, J. R., and Hancock, R. E. (2007) An anti-infective peptide that selectively modulates the innate immune response Nat. Biotechnol. 25, 465-472
7. Nolan, E. M. and Walsh, C. T. (2009) How nature morphs peptide scaffolds into antibiotics ChemBioChem 10, 34-53
8. Marr, A. K., Gooderham, W. J., and Hancock, R. E. (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook Curr. Opin. Pharmacol. 6, 468-472
9. Radzishevsky, I. S., Rotem, S., Zaknoon, F., Gaidukov, L., Dagan, A., and Mor, A. (2005) Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides Antimicrob. Agents Chemother. 49, 2412-2420
10. Scott, R. W., DeGrado, W. F., and Tew, G. N. (2008) De novo designed synthetic mimics of antimicrobial peptides Curr. Opin. Biotechnol. 19, 620-627
11. Vagner, J., Qu, H., and Hruby, V. J. (2008) Peptidomimetics, a synthetic tool of drug discovery Curr. Opin. Chem. Biol. 12, 292-296
12. Thayer, A. M. (2011) Improving peptides Chem. Eng. News 89, 13-20
13. Radzishevsky, I. S., Rotem, S., Bourdetsky, D., Navon-Venezia, S., Carmeli, Y., and Mor, A. (2007) Improved antimicrobial peptides based on acyl-lysine oligomers Nat. Biotechnol. 25, 657-659
14. Liu, D. and DeGrado, W. F. (2001) De novo design, synthesis, and characterization of antimicrobial beta-peptides J. Am. Chem. Soc. 123, 7553-7559
15. Porter, E. A., Weisblum, B., and Gellman, S. H. (2002) Mimicry of host-defense peptides by unnatural oligomers: antimicrobial beta-peptides J. Am. Chem. Soc. 124, 7324-7330
16. Fernandez-Lopez, S., Kim, H. S., Choi, E. C., Delgado, M., Granja, J. R., Khasanov, A., Kraehenbuehl, K., Long, G., Weinberger, D. A., Wilcoxen, K. M., and Ghadiri, M. R. (2001) Antibacterial agents based on the cyclic D,L-alpha-peptide architecture Nature 412, 452-455
17. Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A., Dias, R. L., Misson, P. E., Henze, H., Zumbrunn, J., Gombert, F. O., Obrecht, D., Hunziker, P., Schauer, S., Ziegler, U., Kach, A., Eberl, L., Riedel, K., DeMarco, S. J., and Robinson, J. A. (2010) Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa Science 327, 1010-1013
18. Goodson, B., Ehrhardt, A., Ng, S., Nuss, J., Johnson, K., Giedlin, M., Yamamoto, R., Moos, W. H., Krebber, A., Ladner, M., Giacona, M. B., Vitt, C., and Winter, J. (1999) Characterization of novel antimicrobial peptoids Antimicrob. Agents Chemother. 43, 1429-1434
19. Simon, R. J., Kania, R. S., Zuckermann, R. N., Huebner, V. D., Jewell, D. A., Banville, S., Ng, S., Wang, L., Rosenberg, S., and Marlowe, C. K. 1992, Peptoids: a modular approach to drug discovery Proc. Natl. Acad. Sci. U.S.A. 89, 9367-9371
20. Zuckermann, R. N., Kerr, J. M., Kent, S. B. H., and Moos, W. H. (1992) Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis J. Am. Chem. Soc. 114, 10646-10647
21. Miller, S. M., Simon, R. J., Ng, S., Zuckermann, R. N., Kerr, J. M., and Moos, W. H. (1995) Comparison of the proteolytic susceptibilities of homologous L-amino acid, D-amino acid, and N-substituted clycine peptide and peptoid oligomers Drug Dev. Res. 35, 20-32
22. Miller, S. M., Simon, R. J., Ng, S., Zuckermann, R. N., Kerr, J. M., and Moos, W. H. (1994) Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers Bioorg. Med. Chem. Lett. 4, 2657-2662
23. Kwon, Y. U. and Kodadek, T. (2007) Quantitative evaluation of the relative cell permeability of peptoids and peptides J. Am. Chem. Soc. 129, 1508-1509
24. Tan, N. C., Yu, P., Kwon, Y. U., and Kodadek, T. (2008) High-throughput evaluation of relative cell permeability between peptoids and peptides Bioorg. Med. Chem. 16, 5853-5861
25. Udugamasooriya, D. G., Dineen, S. P., Brekken, R. A., and Kodadek, T. (2008) A peptoid "antibody surrogate" that antagonizes VEGF receptor 2 activity J. Am. Chem. Soc. 130, 5744-5752
26. Astle, J. M., Udugamasooriya, D. G., Smallshaw, J. E., and Kodadek, T. (2008) A VEGFR2 antagonist and other peptoids evade immune recognition Int. J. Pept. Res. Ther. 14, 223-227
27. Fowler, S. A. and Blackwell, H. E. (2009) Structure-function relationships in peptoids: recent advances toward deciphering the structural requirements for biological function Org. Biomol. Chem. 7, 1508-1524
28. Yoo, B. and Kirshenbaum, K. (2008) Peptoid architectures: elaboration, actuation, and application Curr. Opin. Chem. Biol. 12, 714-721
29. Zuckermann, R. N. and Kodadek, T. (2009) Peptoids as potential therapeutics Curr. Opin. Mol. Ther. 11, 299-307
30. Seo, J., Lee, B.-C., and Zuckermann, R. N. (2011) Peptoids: synthesis, characterization and nanostructures, in Comprehensive Biomaterials (Ducheyne, P., Healy, K. E., Hutmacher, D. W., Grainger, D. W., and Kirkpatric, C. J., Ed.) pp 53-76, Elsevier.
31. Patch, J. A. and Barron, A. E. (2003) Helical peptoid mimics of magainin-2 amide J. Am. Chem. Soc. 125, 12092-12093
32. Chongsiriwatana, N. P., Patch, J. A., Czyzewski, A. M., Dohm, M. T., Ivankin, A., Gidalevitz, D., Zuckermann, R. N., and Barron, A. E. (2008) Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides Proc. Natl. Acad. Sci. U.S.A. 105, 2794-2799
33. Chongsiriwatana, N. P., Miller, T. M., Wetzler, M., Vakulenko, S., Karlsson, A. J., Palecek, S. P., Mobashery, S., and Barron, A. E. (2011) Short alkylated peptoid mimics of antimicrobial lipopeptides Antimicrob. Agents Chemother. 55, 417-420
34. Chongsiriwatana, N. P., Wetzler, M., and Barron, A. E. (2011) Functional synergy between antimicrobial peptoids and peptides against gram-negative bacteria Antimicrob. Agents Chemother. 55, 5399-5402
35. Kapoor, R., Wadman, M. W., Dohm, M. T., Czyzewski, A. M., Spormann, A. M., and Barron, A. E. (2011) Antimicrobial peptoids are effective against pseudomonas aeruginosa biofilms Antimicrob. Agents Chemother. 55, 3054-3057
36. Kapoor, R., Eimerman, P. R., Hardy, J. W., Cirillo, J. D., Contag, C. H., and Barron, A. E. (2011) Efficacy of antimicrobial peptoids against mycobacterium tuberculosis Antimicrob. Agents Chemother. 55, 3058-3062
37. Schroder, T., Niemeier, N., Afonin, S., Ulrich, A. S., Krug, H. F., and Brase, S. (2008) Peptoidic amino- and guanidinium-carrier systems: targeted drug delivery into the cell cytosol or the nucleus J. Med. Chem. 51, 376-379
38. Wu, C. W., Sanborn, T. J., Huang, K., Zuckermann, R. N., and Barron, A. E. (2001) Peptoid oligomers with alpha-chiral, aromatic side chains: Sequence requirements for the formation of stable peptoid helices J. Am. Chem. Soc. 123, 6778-6784
39. Sanborn, T. J., Wu, C. W., Zuckermann, R. N., and Barron, A. E. (2002) Extreme stability of helices formed by water-soluble poly-N-substituted glycines (polypeptoids) with alpha-chiral side chains Biopolymers 63, 12-20
40. Armand, P., Kirshenbaum, K., Falicov, A., Dunbrack, R. L., Jr., Dill, K. A., Zuckermann, R. N., and Cohen, F. E. (1997) Chiral N-substituted glycines can form stable helical conformations Fold. Des. 2, 369-375
41. Kirshenbaum, K., Barron, A. E., Goldsmith, R. A., Armand, P., Bradley, E. K., Truong, K. T., Dill, K. A., Cohen, F. E., and Zuckermann, R. N. (1998) Sequence-specific polypeptoids: a diverse family of heteropolymers with stable secondary structure Proc. Natl. Acad. Sci. U.S.A. 95, 4303-4308
42. Wu, C. W., Kirshenbaum, K., Sanborn, T. J., Patch, J. A., Huang, K., Dill, K. A., Zuckermann, R. N., and Barron, A. E. (2003) Structural and spectroscopic studies of peptoid oligomers with alpha-chiral aliphatic side chains J. Am. Chem. Soc. 125, 13525-13530
43. Armand, P., Kirshenbaum, K., Goldsmith, R. A., Farr-Jones, S., Barron, A. E., Truong, K. T., Dill, K. A., Mierke, D. F., Cohen, F. E., Zuckermann, R. N., and Bradley, E. K. (1998) NMR determination of the major solution conformation of a peptoid pentamer with chiral side chains Proc. Natl. Acad. Sci. U.S.A. 95, 4309-4314
44. Huang, W., Seo, J., Willingham, S. B., Czyzewski, A. M., Gonzalgo, M. L., Weissman, I. L., and Barron, A. E. unpublished results.
45. Akhtar, M. S., Qaisar, A., Irfanullah, J., Iqbal, J., Khan, B., Jehangir, M., Nadeem, M. A., Khan, M. A., Afzal, M. S., ul-Haq, I., and Imran, M. B. (2005) Antimicrobial peptide Tc-99m-ubiquicidin 29-41 as human infection-imaging agent: Clinical trial J. Nucl. Med. 46, 567-573
46. Brouwer, C. P. J. M., Wulferink, M., and Welling, M. M. (2008) The pharmacology of radiolabeled cationic antimicrobial peptides J. Pharm. Sci. 97, 1633-1651
47. Ge, Y., MacDonald, D. L., Holroyd, K. J., Thornsberry, C., Wexler, H., and Zasloff, M. (1999) In vitro antibacterial properties of pexiganan, an analog of magainin Antimicrob. Agents Chemother. 43, 782-788
48. Gottler, L. M. and Ramamoorthy, A. (2009) Structure, membrane orientation, mechanism, and function of pexiganan - a highly potent antimicrobial peptide designed from magainin Biochim. Biophys. Acta 1788, 1680-1686
49. Lipsky, B. A., Holroyd, K. J., and Zasloff, M. (2008) Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream Clin. Infect. Dis. 47, 1537-1545
50. Ametamey, S. M., Honer, M., and Schubiger, P. A. (2008) Molecular imaging with PET Chem. Rev. 108, 1501-1516
51. Miao, Z., Ren, G., Liu, H., Jiang, L., and Cheng, Z. (2010) Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein Bioconjugate Chem. 21, 947-954
52. Cheng, Z., Xiong, Z., Subbarayan, M., Chen, X., and Gambhir, S. S. (2007) 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression Bioconjugate Chem. 18, 765-772
53. Burkoth, T. S., Fafarman, A. T., Charych, D. H., Connolly, M. D., and Zuckermann, R. N. (2003) Incorporation of unprotected heterocyclic side chains into peptoid oligomers via solid-phase submonomer synthesis J. Am. Chem. Soc. 125, 8841-8845
54. Montalbetti, C. A. G. N. and Falque, V. (2005) Amide bond formation and peptide coupling Tetrahedron 61, 10827-10852
55. Cheng, Z., Chen, J. Q., Miao, Y., Owen, N. K., Quinn, T. P., and Jurisson, S. S. (2002) Modification of the structure of a metallopeptide: Synthesis and biological evaluation of (111)in-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues J. Med. Chem. 45, 4588-4588
56. Ramamoorthy, A., Thennarasu, S., Lee, D. K., Tan, A., and Maloy, L. (2006) Solid-state NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from magainin 2 and melittin Biophys. J. 91, 206-216
57. Mello, M. E., Flamini, R. C., Corbo, R., and Mamede, M. (2009) Radioiodine concentration by the thymus in differentiated thyroid carcinoma: report of five cases Arq. Bras. Endocrinol. Metabol. 53, 874-879
58. Connolly, L. P. and Connolly, S. A. (2003) Thymic uptake of radiopharmaceuticals Clin. Nucl. Med. 28, 648-651
59. Wang, Y., Lin, H., Tullman, R., Jewell, C. F., Jr., Weetall, M. L., and Tse, F. L. (1999) Absorption and disposition of a tripeptoid and a tetrapeptide in the rat Biopharm. Drug Dispos. 20, 69-75
60. Hagenbuch, B. (2010) Drug uptake systems in liver and kidney: a historic perspective Clin. Pharmacol. Ther. 87, 39-47
61. van Montfoort, J. E., Hagenbuch, B., Groothuis, G. M., Koepsell, H., Meier, P. J., and Meijer, D. K. (2003) Drug uptake systems in liver and kidney Curr. Drug Metab. 4, 185-211
62. Silverman, R. B. (2004) The Organic Chemistry of Drug Design and Drug Action, 2nd ed., Elsevier Academic Press, USA.
63. Foltz, M., van der Pijl, P. C., and Duchateau, G. S. (2010) Current in vitro testing of bioactive peptides is not valuable J. Nutr. 140, 117-118
64. Lee, H. J. (2002) Protein drug oral delivery: the recent progress Arch. Pharm. Res. 25, 572-584
65. Simpson, L. S., Burdine, L., Dutta, A. K., Feranchak, A. P., and Kodadek, T. (2009) Selective toxin sequestrants for the treatment of bacterial infections J. Am. Chem. Soc. 131, 5760-5762
66. Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., and Rothbard, J. B. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters Proc. Natl. Acad. Sci. U.S.A. 97, 13003-13008